KWF
Development Call
12:00; full proposal deadline 16 March 2027
Last updated:
The KWF Development Call funds Dutch cancer researchers to advance projects across all research phases, from creating new modalities through clinical and implementation stages, with a focus on translational impact. The call is open to Research Projects, Unique High-Risk proposals, and Consortia, with a mandatory development plan outlining steps, stakeholders, feasibility, and risk mitigation. Two-stage review (pre-proposal then full proposal) runs annually, with PACO (patient and charity organisation) input weighted at 30% of the evaluation.
Details
| Funder | KWF |
| Deadline | 6 October 2026 |
| Consortium | Optional — collaboration with private enterprises encouraged for public-private partnerships; Consortia is also a distinct application type requiring interviews |
| Application | 2-stage: pre-proposal (deadline 6 October 2026) → full proposal (deadline 16 March 2027); consortium interviews May 2027; funding decision July 2027 |
| Frequency | Annual |
| Next round | 2027-07 |
| Eligible countries | NL |
Eligibility & scope
Development Call funds translation of research findings into practice for Creation of Modality, Preclinical, Clinical or Implementation research phases; application types include Research Project, Unique High-Risk and Consortia. Multicenter GI cancer trials with ≥4 centers require a support letter from the relevant national research group at full-proposal stage.
Who Should Apply
- •Researchers based at Dutch academic, hospital, or recognised research institutions
- •All application types: single Research Projects, Unique High-Risk proposals, or multi-partner Consortia
- •Cancer research spanning creation of modality, preclinical, clinical, and implementation phases
- •Projects with clear development pathway and stakeholder engagement beyond academia
- •Applicants not submitting to competing thematic calls (biomarker validation, PIPELINE, INTER-LOCAL, pancreatic screening)
Key Dates
- •Pre-proposal deadline: 6 October 2026 at 12:00 noon (opens 28 July 2026)
- •Full proposal deadline: 16 March 2027 at 12:00 noon (opens January 2027)
- •Consortium interviews in May 2027; funding decision July 2027
Tips for Applicants
- ✓Include a genuine development plan with concrete steps, identified stakeholders, and explicit risk mitigation, this is mandatory and shapes early triage.
- ✓Patient and charity organisation input (PACO) counts for 30% of the score; draft your lay summary and patient engagement section with care, not as an afterthought.
- ✓If applying as a Consortium, prepare for interview in May 2027; single Research Project and High-Risk proposals do not require interview, reducing burden.
Frequently Asked Questions
What types of cancer research does the KWF Development Call fund?
The call is open to research across all cancer types and phases: creation of modality, preclinical, clinical, and implementation. Projects must exclude those falling within specific thematic calls (biomarker validation, PIPELINE, INTER-LOCAL, pancreatic screening).
Can I apply as a consortium to the KWF Development Call?
Yes, the call accepts Research Projects, Unique High-Risk proposals, and multi-partner Consortia. Consortium applications require an interview in May 2027; other application types do not.
What is the pre-proposal and full proposal timeline?
Pre-proposal deadline is 6 October 2026 at 12:00 noon; full proposal deadline is 16 March 2027 at 12:00 noon. Funding decisions are expected in July 2027.
How much weight does patient and charity input have in KWF Development Call review?
Patient and charity organisation (PACO) review is weighted at 30% of the overall evaluation score.
Who is eligible to apply to the KWF Development Call?
Researchers based at Dutch academic, hospital, or recognised research institutions are eligible.
Related on Grantsby
- KWF writing tips & FAQ
Evaluation criteria, proposal structure, common mistakes.
Summary generated by AI based on published grant information. Always verify details on the funder's website.
Similar grants
Pipeline
KWFDeadline: 8 Dec 2026€1M–€2.5M (Phase I/I-II); €1M–€5M (Phase II/III)Proof of Concept
KWFDeadline: 22 Sept 2026Up to €150,000 incl. VATDiscovery Programme Award
Cancer Research UKDeadline: 29 Sept 2026Up to £2.5mDrug Development Project
Cancer Research UKClinical Research Funding Scheme
Cancer Research UKDeadline: 3 Dec 2026Flexible; module dependent
Browse Related
Could Development Call be right for you?
Deadline in 23 days. See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →